Impact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US Population

BACKGROUND: Evidence of poor patient adherence to medications for chronic obstructive pulmonary disease (COPD) is well-documented, but its impact on disease exacerbation rates and associated healthcare costs remains unclear. OBJECTIVE: To assess the association between adherence levels to different...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am Health Drug Benefits
Hlavní autoři: Davis, Jill R., Wu, Bingcao, Kern, David M., Tunceli, Ozgur, Fox, Kathleen M., Horton, John, Legg, Randall F., Trudo, Frank
Médium: Artigo
Jazyk:Inglês
Vydáno: Engage Healthcare Communications, LLC 2017
Témata:
Clinical
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5470247/
https://ncbi.nlm.nih.gov/pubmed/28626506
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky